66 research outputs found
Interaction among sex, aging, and epigenetic processes concerning visceral fat, insulin resistance, and dyslipidaemia
The distribution of adipose tissue is influenced by gender and by age, shifting from
subcutaneous to visceral depots with longevity, increasing the development of several
aging-related diseases and manifestations such as obesity, metabolic syndrome, and
insulin resistance. Epigenetics might have an important role in aging processes.
The aim of this research was to investigate the interactions between aging and
epigenetic processes and the role of visceral adipose tissue, insulin resistance, and
dyslipidaemia. Two different study samples of 366 and 269 adult participants were
analyzed. Anthropometric, biochemical (including the triglycerides-glucose (TyG) index),
and blood pressure measurements were assessed following standardized methods.
Body composition measurements by Dual-energy X-ray absorptiometry (DXA) were
also performed for the second sample. Methylation data were assessed by Infinium
Human Methylation BeadChip (Illumina) in peripheral white blood cells. Epigenetic age
acceleration was calculated using the methods DNAmAge (AgeAcc) and GrimAge
(AgeAccGrim). Age acceleration (AgeAccGrim) showed better correlations than AgeAcc
with most of the measured variables (waist circumference, glucose, HOMA-IR,
HDL-cholesterol, triglycerides, and TyG index) for the first sample. In the second sample,
all the previous correlations were confirmed, except for HOMA-IR. In addition, many of
the anthropometrical measurements assessed by DXA and C-reactive protein (CRP) were
also statistically associated with AgeAccGrim. Associations separated by sex showed
statistically significant correlations between AgeAccGrim and HDL-cholesterol or CRP in
women, whereas, in men, the association was with visceral adipose tissue mass DXA,
triglycerides and TyG index. Linear regression models (model 1 included visceral adipose
tissue mass DXA and TyG index and model 2 included HDL-cholesterol and CRP) showed
a significant association for men concerning visceral adipose tissue mass DXA and TyG
index, while HDL-cholesterol and CRP were associated in women. Moreover, structural
equation modeling showed that the TyG index was mediating the majority of the visceral adipose tissue mass action on age acceleration. Collectively, these findings showed that
there are different mechanisms affecting epigenetic age acceleration depending on sex.
The identified relationships between epigenetic age acceleration and disease markers
will contribute to the understanding of the development of age-related diseases
Association of the SH2B1 rs7359397 gene polymorphism with steatosis severity in subjects with obesity and non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. Some genetic variants might be involved in the progression of this disease. The study hypothesized that individuals with the rs7359397 T allele have a higher risk of developing severe stages of NAFLD compared with non-carriers where dietary intake according to genotypes could have a key role on the pathogenesis of the disease. SH2B1 genetic variant was genotyped in 110 overweight/obese subjects with NAFLD. Imaging techniques, lipidomic analysis and blood liver biomarkers were performed. Body composition, general biochemical and dietary variables were also determined. The SH2B1 risk genotype was associated with higher HOMA-IR p equal 0.001; and Fatty Liver Index (FLI) p equal 0.032. Higher protein consumption (p equal 0.028), less mono-unsaturated fatty acid and fiber intake (p equal 0.045 and p equal 0.049, respectively), was also referred to in risk allele genotype. Lipidomic analysis showed that T allele carriers presented a higher frequency of non-alcoholic steatohepatitis (NASH) (69.1/100 vs. 44.4/100; p equal 0.006). In the genotype risk group, adjusted logistic regression models indicated a higher risk of developing an advanced stage of NAFLD measured by FLI (OR 2.91) and ultrasonography (OR 4.15). Multinomial logistic regression models showed that risk allele carriers had higher liver fat accumulation risk (RRR 3.93) and an increased risk of NASH (RRR 7.88). Consequently, subjects carrying the T allele were associated with a higher risk of developing a severe stage of NAFLD. These results support the importance of considering genetic predisposition in combination with a healthy dietary pattern in the personalized evaluation and management of NAFLD
Interaction between an adcy3 genetic variant and two weight-lowering diets affecting body fatness and body composition outcomes depending on macronutrient distribution: a randomized trial
The adenylate cyclase 3 (ADCY3) gene is involved in the regulation of several metabolic
processes including the development and function of adipose tissue. The effects of the ADCY3
rs10182181 genetic variant on changes in body composition depending on the macronutrient
distribution intake after 16 weeks of the dietary intervention were tested. The ADCY3 genetic
variant was genotyped in 147 overweight or obese subjects, who were randomly assigned to one
of the two diets varying in macronutrient content: a moderately-high-protein diet and a low-fat
diet. Anthropometric and body composition measurements (DEXA scan) were recorded. Significant
interactions between the ADCY3 genotype and dietary intervention on changes in weight, waist
circumference, and body composition were found after adjustment for covariates. Thus, in the
moderately-high-protein diet group, the G allele was associated with a lower decrease of fat mass,
trunk and android fat, and a greater decrease in lean mass. Conversely, in the low-fat diet group
carrying the G allele was associated with a greater decrease in trunk, android, gynoid, and visceral
fat. Subjects carrying the G allele of the rs10182181 polymorphism may benefit more in terms of
weight loss and improvement of body composition measurements when undertaking a hypocaloric
low-fat diet as compared to a moderately-high-protein diet
The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial
The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing worldwide. NAFLD management is mainly focused on weight loss, but the optimal characteristics of the diet demand further investigation. This study aims to evaluate the effects of two personalized energy-restricted diets on the liver status in overweight or obese subjects with NAFLD after a 6 months follow-up. Ninety-eight individuals from the Fatty Liver in Obesity (FLiO) study were randomized into two groups and followed different energy-restricted diets. Subjects were evaluated at baseline and after 6 months. Diet, anthropometry, body composition, and biochemical parameters were evaluated. Liver assessment included ultrasonography, Magnetic Resonance Imaging, elastography, and determination of transaminases. Both dietary groups significantly improved their metabolic and hepatic markers after the intervention, with no significant differences between them. Multivariate regression models evidenced a relationship between weight loss, adherence to the Mediterranean Diet (MedDiet), and a decrease in liver fat content, predicting up to 40.9% of its variability after 6 months. Moreover, the antioxidant capacity of the diet was inversely associated with liver fat content. Participants in the group with a higher adherence to the MedDiet showed a greater reduction in body weight, total fat mass, and hepatic fat. These results support the benefit of energy-restricted diets, high adherence to the MedDiet, and high antioxidant capacity of the diet for the management of NAFLD in individuals with overweight or obesity
Interplay of glycemic index, glycemic load, and dietary antioxidant capacity with insulin resistance in subjects with a cardiometabolic risk profile
Background: Dietary total antioxidant capacity (TAC), glycemic index (GI), and glycemic
load (GL) are accepted indicators of diet quality, which have an effect on dietâdisease relationships.
The aim of this study was to evaluate potential associations of dietary TAC, GI, and GL with variables
related to nutritive status and insulin resistance (IR) risk in cardiometabolic subjects. Methods: A total
of 112 overweight or obese adults (age: 50.8 ± 9 years old) were included in the trial. Dietary intake
was assessed by a validated 137-item food frequency questionnaire (FFQ), which was also used
to calculate the dietary TAC, GI, and GL. Anthropometrics, blood pressure, body composition by
dual-energy X-ray absorptiometry (DXA), glycemic and lipid profiles, C-reactive protein (CRP),
as well as fatty liver quantification by magnetic resonance imaging (MRI) were assessed. Results:
Subjects with higher values of TAC had significantly lower circulating insulin concentration and
homeostatic model assessment of insulin resistance (HOMA-IR). Participants with higher values of
HOMA-IR showed significantly higher GI and GL. Correlation analyses showed relevant inverse
associations of GI and GL with TAC. A regression model evidenced a relationship of HOMA-IR
with TAC, GI, and GL. Conclusion: This data reinforces the concept that dietary TAC, GI, and GL
are potential markers of diet quality, which have an impact on the susceptible population with a
cardiometabolic risk profile
Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study
Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome. Obesity and unhealthy dietary habits are described as risk factors for NAFLD. The aim of this study was to investigate the association between the consumption of different animal protein sources and hepatic status in NAFLD adults. A total of 112 overweight/obese participants with NAFLD from Fatty Liver in Obesity (FLiO) study were evaluated at baseline. Diet, body composition, and biochemical variables were evaluated. Hepatic status was also assessed by Magnetic Resonance Imaging, ultrasonography, and elastography. Red meat consumption showed a positive relationship with liver iron content (r = 0.224; p = 0.021) and ferritin concentration (r = 0.196; p = 0.037). Processed meat consumption exhibited a positive association with liver iron content (r = 0.308; p = 0.001), which was also found in the quantile regression (ÎČ = 0.079; p = 0.028). Fish consumption was related with lower concentration of ferritin (r = -0.200; p = 0.034). This association was further evidenced in the regression model (ÎČ = -0.720; p = 0.033). These findings suggest that the consumption of different animal protein sources differentially impact on liver status in obese subjects with NAFLD, showing fish consumption as a healthier alternative for towards NAFLD features
Técnicas terapéuticas endovasculares
Percutaneous and endovascular techniques have
shown their efficacy in the treatment of a great variety
of pathologies. The advances in diagnostic imaging as
well as the development of new materials have made it
possible to carry out new procedures that were
unthinkable not many years ago. The irruption of this
new form of treating patients has had, is having, and
will have a clear impact on the multidisciplinary
approach to numerous diseases
Predictive value of serum ferritin in combination with alanine aminotransferase and glucose levels for noninvasive assessment of NAFLD: Fatty liver in obesity (FLiO) study
The identification of affordable noninvasive biomarkers for the diagnosis and characterization of nonalcoholic fatty liver disease (NAFLD) is a major challenge for the research community. This study aimed to explore the usefulness of ferritin as a proxy biomarker of NAFLD condition, alone or in combination with other routine biochemical parameters. Subjects with overweight/obesity and ultrasound-confirmed liver steatosis (n = 112) from the Fatty Liver in Obesity (FLiO) study were assessed. The hepatic evaluation considered magnetic resonance imaging, ultrasonography, and credited routine blood liver biomarkers. Anthropometry and body composition, dietary intake (by means of a validated 137-item food frequency questionnaire), and specific biochemical markers were also determined. Serum ferritin levels were analyzed using a chemiluminescent microparticle immunoassay kit. Lower serum ferritin concentrations were associated with general better liver health and nutritional status. The evaluation of ferritin as a surrogate of liver damage by means of quantile regression analyses showed a positive association with alanine aminotransferase (ALT) (ÎČ = 19.21; p †0.001), liver fat content (ÎČ = 8.70; p = 0.008), and hepatic iron (ÎČ = 3.76; p †0.001), after adjusting for potential confounders. In receiver operating characteristic (ROC) analyses, the panel combination of blood ferritin, glucose, and ALT showed the best prediction for liver fat mass (area under the curve (AUC) 0.82). A combination of ferritin and ALT showed the higher predictive ability for estimating liver iron content (AUC 0.73). This investigation demonstrated the association of serum ferritin with liver health as well as with glucose and lipid metabolism markers in subjects with NAFLD. Current findings led to the identification of ferritin as a potential noninvasive predictive biomarker of NAFLD, whose surrogate value increased when combined with other routine biochemical measurements (glucose/ALT)
Osteosarcoma: correlation between radiological and histological changes after intra-arterial chemotherapy
The statistical correlation between three different radiological methods (conventional radiography, computed tomography and angiography) and tumor necrosis (TN) of the resected specimen have been studied in a series of 31 patients diagnosed with osteosarcoma (OS). They were treated with a multidisciplinary approach including intraarterial and intravenous chemotherapy followed by limb salvage procedures, plus intraoperative radiotherapy and adjuvant chemotherapy. A clear statistical correlation has been obtained between TN and angiography (p = 0.02) and between TN and two specific radiological signs: 'tumoral stain and neovascularity' (p = 0.02) and 'peritumoral fat planes' (p = 0.05). Conventional radiography, computed tomography and other radiological signs studied (nutrient vessel, soft tissue mass and central peripheral calcifications) did not show any significant correlation with TN. These results seem to suggest that angiography is a method to evaluate TN preoperatively and also to define the efficacy of neoadjuvant chemotherapy in OS
Association between sleep disturbances and liver status in obese subjects with nonalcoholic fatty liver disease: a comparison with healthy controls
The relevance of sleep patterns in the onset or evolution of nonalcoholic fatty liver disease
(NAFLD) is still poorly understood. Our aim was to investigate the association between sleep
characteristics and hepatic status indicators in obese people with NAFLD compared to normal weight
non-NAFLD controls. Ninety-four overweight or obese patients with NAFLD and 40 non-NAFLD
normal weight controls assessed by abdominal ultrasonography were enrolled. Hepatic status
evaluation considered liver stiffness determined by Acoustic Radiation Force Impulse elastography
(ARFI) and transaminases. Additionally, anthropometric measurements, clinical characteristics, and
biochemical profiles were determined. Sleep features were evaluated using the Pittsburgh Sleep
Quality Index (PSQI). Hepatic status parameters, anthropometric measurements, and clinical and
biochemical markers differed significantly in NAFLD subjects compared to controls, as well as sleep
efficiency, sleep disturbance score, and sleep quality score. In the NAFLD group, a higher prevalence
of short sleep duration (p = 0.005) and poor sleep quality (p = 0.041) were found. Multivariate-adjusted
odds ratio (95% confidence interval) for NAFLD considering sleep disturbance was 1.59 (1.11â2.28).
Regression models that included either sleep disturbance or sleep quality predicted up to 20.3% and
20.4% of the variability of liver stiffness, respectively, and after adjusting for potential confounders.Current findings suggest that sleep disruption may be contributing to the pathogenesis of NAFLD as
well as the alteration of the liver may be affecting sleep patterns. Consequently, sleep characteristics
may be added to the list of modifiable behaviors to consider in health promotion strategies and in the
prevention and management of NAFLD
- âŠ